Deals channel feed – Endpoints News

Deals channel feed

AbbVie partners with Neomorph in latest molecular glue deal

4 months ago

BioMarin turns to ex-Roche dealmaker James Sabry to build ‘next version’ of 27-year-old company

4 months ago

Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma

4 months ago

Another US biotech emerges with drug candidate from China-based Keymed

4 months ago

A mixed year for deals and dollars left biotech execs hungry for a better 2025

4 months ago

Regenxbio sells Hunter syndrome license with FDA filing underway

4 months ago

Australia's BioCina and NovaCina join forces to make one CDMO

4 months ago

Daiichi Sankyo brings Glycotope antibody in-house for $132.5M

4 months ago

Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

4 months ago

AstraZeneca, CRISPR tools supplier ink gene editing enzyme licensing deal

4 months ago

Updated: J&J to buy Intra-Cellular for $14.6B in latest neuroscience bet

4 months ago

#JPM25 live blog day 1: How will Trump 2.0 impact the biopharma industry? Scott Gottlieb, Bob Nelsen share perspectives

4 months ago

Gilead taps into STAT6 space via $250M deal with Leo Pharma

4 months ago

GSK kicks off JPM dealmaking with $1B+ buyout of IDRx and its rare cancer drug

4 months ago

Lantheus to buy Life Molecular Imaging for $350M, netting Alzheimer's diagnostic

4 months ago

J&J looks at potential bid for Intra-Cellular — report

4 months ago

Biogen offers to buy out struggling neuro partner Sage Therapeutics

4 months ago

City Therapeutics, Bausch + Lomb partner on preclinical RNAi eye drug

4 months ago

Four biotechs emerge with $800M and in-licensed assets on Friday

4 months ago

Another biotech scoops up asset from China-based Keymed and nabs $180M

4 months ago

Lilly ventures into pulmonary fibrosis with startup Mediar

4 months ago

After lackluster 2024, biopharma industry prays stalled M&A will finally move into gear

4 months ago

Versant unveils Light Horse with $62M and a partnership with Novartis

4 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

4 months ago

First page Previous page 3 4 567 8 9 Next page Last page